The specific aim of this project is to analyze the biosynthesis and function-structure relationships of polymophic variants of H-2 linked complement projects, C4, S1p, C2, and B. We plan to continue one of our long-term objectives, the genetics, regulation, function and structure of mouse C4 and S1p. This project will emphasize functional aspects of C4 and S1p, especially as function relates to structure in polymorphic variants, and the biosynthesis of C4 and S1p by short-term in vitro mouse peritoneal macrophage and hepatocyte cultures. The methodology primarily involves biosynthetic labeling of C4 and S1p with radioactive sugar and amino acid precursors, immunoprecipitation and subsequent analysis of the precipitated complex by SDS-PAGE. This modus operandi will also be applied to B since antibodies are available and to C2 when the antibodies are produced. Sensitive hemolytic assays are now available for C4, C2 and B and polymorphic variants are known for each component. In the previous four years, much has been learned about the genetic regulation and function-structure relationships of mouse C4. [An important observation, that the secreted form of mouse and human C4 is about 5000 daltons larger than the major form of C4 in plasma, will be analyzed in regards to the protease responsible for the cleavage and function of the peptide released. We now plan to extend these studies to S1p, B and C2 while continuing our work on C4.] We believe our studies on C4 biosynthesis will progress to the point that they will become an instructive model of the evolution and control of a mammalian protein. Through continued genetic, structural and functional characterizations of these products, we hope to gain better insights into the basis for their control by the major histocompatibility complex.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI019642-03
Application #
3128989
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1983-09-30
Project End
1988-08-31
Budget Start
1985-09-01
Budget End
1986-08-31
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Washington University
Department
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Guo, Haitao; Aldrich, Carol E; Saputelli, Jeffry et al. (2006) The insertion domain of the duck hepatitis B virus core protein plays a role in nucleocapsid assembly. Virology 353:443-50
Seya, T; Nagasawa, S; Atkinson, J P (1990) C4b-binding protein and a 60,000-Dalton plasma protein share antigenic determinants with membrane cofactor protein of complement. J Immunol 144:2312-20
McNearney, T; Ballard, L; Seya, T et al. (1989) Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells. J Clin Invest 84:538-45
Bora, N S; Lublin, D M; Kumar, B V et al. (1989) Structural gene for human membrane cofactor protein (MCP) of complement maps to within 100 kb of the 3' end of the C3b/C4b receptor gene. J Exp Med 169:597-602
Seya, T; Atkinson, J P (1989) Functional properties of membrane cofactor protein of complement. Biochem J 264:581-8
Seya, T; Ballard, L L; Bora, N S et al. (1988) Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes. Eur J Immunol 18:1289-94
Shreffler, D C (1988) Seventy-five years of immunology: the view from the MHC. J Immunol 141:1791-8
Manthei, U; Nickells, M W; Barnes, S H et al. (1988) Identification of a C3b/iC3 binding protein of rabbit platelets and leukocytes. A CR1-like candidate for the immune adherence receptor. J Immunol 140:1228-35
Stafford, H A; Tykocinski, M L; Lublin, D M et al. (1988) Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells. Proc Natl Acad Sci U S A 85:880-4
Taillon-Miller, P A; Shreffler, D C (1988) Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. J Immunol 141:2382-7

Showing the most recent 10 out of 24 publications